Found 4 matching trials
Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465) PHASE2 This is a Phase 2, multicenter, open-label study to provide continued suppl...
Show More Status
Active Not Recruiting
Location
Uab Comprehensive Cancer Center
Learn More & Join Trial
INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112) PHASE1 The purpose of this study is to evaluate the safety and tolerability of par...
Show More Location
University of Arizona Cancer Center - Out Pt.
Learn More & Join Trial
A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204) PHASE2 The purpose of this study is to evaluate the safety and efficacy of two par...
Show More Location
University of Alabama At Birmingham Comprehensive Cancer Center
Learn More & Join Trial
A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor PHASE2 This is a Phase 2, open-label, 2-cohort study designed to evaluate the effi...
Show More Location
University of Alabama At Birmingham Comprehensive Cancer Center
Learn More & Join Trial